Characterisation of 11β-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: A comparison with subcutaneous and omental fat

Journal of Endocrinology

Volumn 192, Issue 2, 2007, Pages 279-288

  Bujalska, Iwona J ^a   Durrani, Omar M ^a   Abbott, Joseph ^a   Onyimba, Claire U ^a   Khosla, Pamela ^a   Moosavi, Areeb H ^b   Reuser, Tristan T Q ^b   Stewart, Paul M ^a   Tomlinson, Jeremy W ^a   Walker, Elizabeth A ^a   Rauz, Saaeha ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CD68 ANTIGEN; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 4; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; GLUCOCORTICOID RECEPTOR; LEUKOCYTE ANTIGEN; MESSENGER RNA;

ABDOMINAL FAT; ADIPOCYTE; ARTICLE; AUTOMATION; BODY FAT DISTRIBUTION; CELL DIFFERENTIATION; CELL SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; NORMAL HUMAN; OMENTUM; ORBIT INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; ADIPOSE TISSUE; CELL CULTURE; CYTOLOGY; ENZYMOLOGY; GENETICS; METHODOLOGY; ORBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ABDOMINAL FAT; ADIPOCYTES; ADIPOSE TISSUE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; OMENTUM; ORBIT; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCUTANEOUS FAT;

EID: 33947365646     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/JOE-06-0042     Document Type: Article

References (56)

1. Ajjan RA & Weetman AP 2004 New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy. Journal of Endocrinological Investigation 27 237-245.
2. Alberts P, Engblom L, Edling N, Forsgren M, Klingström G, Larsson C, Rönquist-Nii Y, Öhman B & Abrahmsén L 2002 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45 1528-1532.
3. Alberts P, Nilsson C, Selen G, Engblom L, Edling N, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M et al. 2003 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144 4755-4762.
4. Bader T, Zoumakis E, Friedberg M, Hiroi N, Chrousos G & Hochberg Z 2002 Human adipose tissue under in vitro inhibition of 11beta-hydroxysteroid dehydrogenase type 1: differentiation and metabolism changes. Hormone and Metabolic Research 34 752-757.
5. Boullu-Ciocca S, Paulmyer-Lacroix O, Fina F, Ouafik LH, Alessi M-C, Oliver C & Grino M 2003 Expression of the mRNAs coding for the glucocorticoid receptor isoforms in obesity. Obesity Research 11 925-929.
6. Bremond-Gignac D, Copin H, Cussenot O, Lassau J-P & Henin D 2004 Anatomical, histological and mesoscopic study of the adipose tissue of the orbit. Surgical and Radiologic Anatomy 26 297-302.
7. Bujalska IJ, Kumar S & Stewart PM 1997 Does central obesity reflect 'Cushing's disease of the omentum'? Lancet 349 1210-1213.
8. Bujalska IJ, Kumar S, Hewison M & Stewart PM. 1999 Differentiation of adipose stromal cells: the roles of glucocorticoids and 11 {beta}-hydroxysteroid dehydrogenase. Endocrinology 140 3188-3196.
9. Bujalska IJ, Walker EA, Hewison M & Stewart PM 2002 A switch in dehydrogenase to reductase activity of 11β-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. Journal of Clinical Endocrinology and Metabolism 87 1205-1210.
10. Bujalska IJ, Draper N, Michialidou Z, Tomlinson JW, White PC, Chapman KE, Walker EA & Stewart PM 2005 Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1. Journal of Molecular Endocrinology 35 675-684.
11. Burnstine MA, Elner SG & Elner VM 1998 Orbital fibroblast chemokine modulation: effects of dexamethasone and cyclosporin A. British Journal of Ophthalmology 82 318-322.
12. Chen B, Tsui S & Smith TJ 2005 IL-1{beta} induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. Journal of Immunology 175 1310-1319.
13. Cooper MS, Walker EA, Bland R, Fraser WD, Hewison M & Stewart PM 2000 Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone. Bone 27 375-381.
14. Cooper MS, Bujalska I, Rabbitt EA, Walker EA, Bland R, Sheppard MC, Hewison M & Stewart PM 2001 Modulation of 11β-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. Journal of Bone and Mineral Research 16 1037-1044.
15. Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M & Stewart PM 2002 Osteoblastic 11β-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. Journal of Bone and Mineral Research 17 979-986.
16. Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I et al. 2003 Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nature Genetics 34 434-439.
17. Gordon S & Taylor PR 2005 Monocyte and macrophage heterogeneity. Nature Reviews. Immunology 5 953-964.
18. Han R & Smith TJ 2005 Induction by IL-lβ of tissue inhibitor of metalloprotemase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-γ. Journal of Immunology 174 3072-3079.
19. Hauner H, Schmid P & Pfeiffer EF 1987 Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. Journal of Clinical Endocrinology and Metabolism 64 832-835.
20. Hermanowski-Vosatka A, Balkovec, JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS et al. 2005 11 {beta)-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. Journal of Experimental Medicine 202 517-527.
21. Heufelder AE 2000 Pathogenesis of ophthalmopathy in autoimmune thyroid eye disease. Reviews in Endocrine and Metabolic Disorders 1 87-95.
22. Heufelder AE & Bahn RS 1994 Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists. Investigative Ophthalmology and Visual Science 35 120-127.
23. Heufelder A-E, Bahn RS & Smith TJ 1992 Regulation by gluccorticoids of interferon gamma-induced HLA-DR antigen expression in cultured human orbital fibroblasts. Clinical Endocrinology 37 59-63.
24. Kaback LA & Smith TJ 1999 Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1{beta} in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. Journal of Clinical Endocrinology and Metabolism 84 4079-4084.
25. Kaminski HJ, Li Z, Richmonds C, Ruff RL & Kusner L 2003 Susceptibility of ocular tissues to autoimmune diseases. Annals of the New York Academy of Sciences 998 362-374.
26. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CRW, Seckl JR et al. 1997 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycaemia on obesity and stress. PNAS 94 14924-14929.
27. Kumar S & Balm RS 2003 Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism 88 4246-4250.
28. Masuzaki H, Paterson J, Shinyama H, Morton NM, Muffins JJ, Seckl JR & Flier JS 2001 A transgenic model of visceral obesity and the metabolic syndrome. Science 294 2166-2170.
29. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MGF, Fleming S, Mullins JJ et al. 2003 Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. Journal of Clinical Investigation 112 83-90.
30. Montague CT, Prins JB, Sanders L, Digby JE & O'Rahilly S 1997 Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 46 342-347.
31. Muhlberg T, Joba W, Spitzweg C, Schworm H-D, Heberling H-J & Heufelder AE 2000 Interleukin-1 receptor antagonist ribonucleic acid and protein expression by cultured Graves' and normal orbital fibroblasts is differentially modulated by dexamethasone and irradiation. Journal of Clinical Endocrinology and Metabolism 85 734-742.
32. Neels JG & Olefsky JM 2006 Inflamed fat: what starts the fire? Journal of Clinical Investigation 116 33-35.
33. Niesler, CU, Siddle K & Prins JB 1998 Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes 47 1365-1368.
34. Onyimba CU, Vijapurapu N, Curnow SJ, Khosla P, Stewart PM, Murray PI, Walker EA & Rauz S 2006 Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye. Journal of Endocrinology 190 483-493.
35. Petruschke T & Hauner H 1993 Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipiclation of newly developed fat cells. Journal of Clinical Endocrinology and Metabolism 76 742-747.
36. Pietiläinen KH, Kannisto K, Korsheninnikova E, Rissanen A, Kaprio, J, Ehrenborg E, Hamsten A & Yki-Järvinen H 2006 Acquired obesity increases CD68 and TNF-α and decreases adiponectin gene expression in adipose tissue - a study in monozygotic twins. Journal of Clinical Endocrinology and Metabolism 91 2776-2781.
37. Prabhakar BS, Bahn RS & Smith TJ 2003 Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocrine Reviews 24 802-835.
38. Prins JB, Niesler CU, Winterford CM, Bright NA, Siddle K, O'Rahilly S, Walker NI & Cameron DP 1997 Tumor necrosis factor-alpha induces apoptosis of human adipose cells. Diabetes 46 1939-1944.
39. Rauz S, Cheung CMG, Wood PJ, Coca-Prados M, Walker EA, Murray PI & Stewart PM 2003 Inhibition of 11β-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension. Quarterly Journal of Medicine 96 481-490.
40. Rootman J 2002 Pathophysiologic patterns of orbital disease. In Diseases of the Orbit: a Multidisciplinary Approach, 2nd edn, Ed. J Rootman. Philadelphia, PA: Lippincott Williams & Wilkins.
41. Smith TJ 2004 Novel aspects of orbital fibroblast pathology. Journal of Endocrinological Investigation 27 246-253.
42. Smith TJ, Sempowski GD, Wang HS, Del Vecchio PJ, Lippe SD & Phipps RP 1995 Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. Journal of Clinical Endocrinology and Metabolism 80 2620-2625.
43. Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP & Sorisky A 2002 Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. Journal of Clinical Endocrinology and Metabolism 87 385.
44. Stewart PM, Murry BA & Mason JI 1994 Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform. Journal of Clinical Endocrinology and Metabolism 79 480-484.
45. Thieringer R, Grande CBL, Carbin L, Cai T, Wong B, Wright SD & Hermanowski-Vosatka A 2001 11β-Hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages. Journal of Immunology 167 30-35.
46. Tomlinson JW, Bujalska I, Stewart PM & Cooper MS 2000 The role of 11β-hydroxysteroid dehydrogenase in central obesity and osteoporosis. Endocrine Research 26 711-722.
47. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M & Stewart PM 2001 Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue specific induction by cytokines. Endocrinology 142 1982-1989.
48. Tomlinson JW, Sinha B, Bujalska I, Hewison M & Stewart PM. 2002 Expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. Journal of Clinical Endocrinology and Metabolism 87 5630-5635.
49. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M & Stewart PM 2004 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Reviews 25 831-866.
50. Valyasevi RW, Jyonoucgi SC, Dutton CM, Munsakul N & Bahn RS 2001 Effect of tumour necrosis factor-α, interferon-γ, and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts. Journal of Clinical Endocrinology and Metabolism 86 903-908.
51. Vikman HL, Hreniuk SP, Kauffman GF, LaNoue KF, Martin LF & Ohisalo JJ 1995 Cyclic AMP and glycerol concentrations in freeze-clamped human omental and subcutaneous adipose tissues. International Journal of Obesity and Related Metabolic Disorders 19 388-391.
52. Weisberg SP, McCann DM, Desai M, Rosenbaum M, Leibel RL & Ferrante AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 112 1796-1808.
53. Wellen KE & Hotamisligil GS 2003 Obesity-induced inflammatory changes in adipose tissue. Journal of Clinical Investigation 112 1785-1788.
54. Wolfram-Gabel R & Kahn JL 2002 Adipose body of the orbit. Clinical Anatomy 15 186-192.
55. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA et al. 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 112 1821-1830.
56. Zhang TY, Ding X & Daynes RA 2005 The expression of 11β-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities. Journal of Immunology 174 879-889.